type here...

CATEGORIES

Blood Conditions

LATEST

123Page 1 of 3

TRENDING

EDITORS CHOICE

Artificial Intelligence, Microbiome, and Predicting Liver Disease

Michael Hunter, MD -
Increasing evidence suggests an interplay between the gut microbiome and nonalcoholic fatty liver disease (NAFLD). The role of the microbiome in the early detection of the condition remains unclear.

The Remarkable Research Of CAR T Therapy: B Cell Cancers

William Haseltine, PhD -
The first installment lays the foundation for understanding how CAR T works. This second piece delves into the use of CAR T to treat B cell cancers.

Addressing Global Income Disparities in Acute Lymphoblastic Leukaemia Care

Christopher Nial -
he stark disparity in the diagnosis and treatment of Acute Lymphoblastic Leukaemia (ALL) between high-income countries (HICs) and low- and middle-income countries (LMICs) highlights a critical issue in global healthcare equity.

Obesity Causes Cancer? It’s Complicated

Michael Hunter, MD -
BEING OVERWEIGHT OR OBESE IS ASSOCIATED with a higher risk of more than a dozen cancers.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories